Enhance your practice with CME and tools that focus on the management of neurological conditions.
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
June 03, 2026
06:00 PM - 07:00 PM CEST
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Understanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Examining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Tau Therapies and Clinical Translation: Mechanistic Approaches
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
Marwan Sabbagh, MD, FAAN
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
June 15, 2026 Chicago, Illinois
Unseen Impact of NPS in AD: Domains and Burden
NPS Psychosis: Circuits, Treatment, and New Hope
07:30 AM - 09:00 AM ET
Friedreich’s Ataxia: Impact of Frataxin Loss
Arnulf Koeppen, MD
BCMA mRNA CAR-T Shows Durable Benefit in MG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NPS Agitation: Evidence and Emerging Mechanisms of Management
Unpacking the Genetics of Friedreich’s Ataxia
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
Advances in Cell-Based Therapy for MS
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.